NLRP3 and early-onset autosomal dominant Alzheimer disease: Additionally, NLRP3 inflammasome inhibitors like Tranilast [70,71] and Oridonin [72,73] have demonstrated potential in preclinical studies for alleviating neuroinflammation and cognitive deficits in Alzheimer’s disease (AD) models.